Authors
Latest:
Dr. Juergens on the IND.226 Trial in Advanced Non-Squamous NSCLCRosalyn Juergens, MD, PhD, assistant professor, Department of Oncology, Division of Medical Oncology, McMaster University, discusses the results of the IND.226 trial, in an interview at the IASLC 17th World Conference on Lung Cancer in Vienna, Austria.
Latest:
Dr. Kaplan on the Treatment of Pediatric Patients With SarcomaRosandra N. Kaplan, MD, investigator, Pediatric Oncology Branch, Head, Tumor Microenvironment Section, National Cancer Institute, discusses the treatment of pediatric patients with sarcoma.
Latest:
Dr. Campelo on the Rationale for the ALTA-1L TrialRosario Garcia Campelo, MD, medical oncologist, University Hospital Caruna, talks about a randomized trial assessing health-related quality of life in patients with ALK-positive non–small cell lung cancer patients who were treated with brigatinib versus crizotinib.
Latest:
Dr. Lai on Risk Factors Associated With GliomaRose K. Lai, MD, clinical associate professor of Neurology, University of Southern California, discusses results of the Glioma International Case Control study.
Latest:
Lessons on Patient Care Learned at HomeThis fellow shares the insights he’s gained from his wife, a pediatric oncology nurse, and how they help in the care he provides.
Latest:
Dr. Chlebowski on How Weight Loss Improves TNBC SurvivalAs few as five pounds of weight loss can make a significant difference for patients with triple-negative breast cancer, says Rowan Chlebowski, MD, PhD, a medical oncologist at the Los Angeles Biomedical Research Institute at the Harbor-UCLA Medical Center.
Latest:
Breast Cancer Chemoprevention: Targeting the Estrogen ReceptorNew strategies to increase the uptake of these proven breast cancer risk-reduction interventions in general clinical practice are needed.
Latest:
Venous Thromboembolism and Cancer: An Opportunity for Pharmacists to Optimize CareThe management of venous thromboembolism (VTE) disorders is well described in the literature, and comprehensive guidelines are available from the American College of Chest Physicians.
Latest:
Clinics Strive to Improve Revenue and Patient Care Amid a Growing "Cost Consciousness"Growing awareness is prompting a revolution in vigilance and attention to detail that has significance both for the quality of care and financial health of practices.
Latest:
Understanding the Implications of Mandatory Vendor Imposition in OncologyThe rising costs of healthcare have caused payers to analyze spending and take measures to contain costs.
Latest:
Dr. Decker on Pembrolizumab With Concurrent Chemoradiotherapy in Inoperable Locally Advanced NSCLCRoy H. Decker, MD, PhD, discusses the use of pembrolizumab with concurrent chemoradiotherapy in patients with inoperable, locally advanced non–small cell lung cancer.
Latest:
Dr. Herbst on Considerations for Frontline Immunotherapy in NSCLCRoy S. Herbst, MD, PhD, discusses considerations for frontline immunotherapy in non–small cell lung cancer.
Latest:
Blood-Based Biomarkers in NSCLCThe potential clinical utility of blood-based biomarkers in non–small cell lung cancer based on recent data presented at ASCO 2021.
Latest:
Dr Herbst on Adjuvant Osimertinib in EGFR-mutant NSCLCRoy S. Herbst, MD, PhD, discusses findings from the overall survival analysis of the phase 3 ADAURA trial of adjuvant osimertinib in patients with stage IB to IIIA resected non–small cell lung cancer harboring EGFR mutations.
Latest:
Immunotherapy for NSCLC: Clinical PearlsFinal takeaways from ASCO 2021 and the use of immunotherapy to treat various types of patients with non–small cell lung cancer.
Latest:
Dr. Roy Weiner on the Importance of Diversity in Cancer ResearchRoy Weiner, MD, Associate Dean for Clinical Research and Training Associate Director of Clinical Research for Tulane Cancer Center discusses the importance of racial and ethnic diversity in cancer research.
Latest:
Addressing Unmet Needs in Medullary Thyroid CancerRozita Yarmand, PhD, assistant professor, Department of Endocrine Neoplasia and Hormonal Disorders-Research, The University of Texas MD Anderson Cancer Center, discusses unmet needs in medullary thyroid cancer.
Latest:
Myeloproliferative Neoplasm Management: Future Directions in CareClosing out their discussion on myeloproliferative neoplasms, key opinion leaders share excitement for future evolutions in the treatment paradigm.
Latest:
Bone Marrow Transplant for Patients With MFExpert panelists review important disease-related and patient-related factors when considering bone marrow transplant in patients with primary myelofibrosis.
Latest:
Role of Symptom Burden in Thrombocythemia and Polycythemia VeraShared insight on how a patient’s symptom burden can impact management strategies within essential thrombocytopenia and polycythemia vera.
Latest:
Dr. Mesa on the Rationale for the MOMENTUM Trial in MyelofibrosisRuben A. Mesa, MD, discusses the rationale for the phase 3 MOMENTUM study in myelofibrosis.
Latest:
Dr. Niesvizky on Sequencing Therapies for Patients With Multiple MyelomaRuben Niesvizky, MD, professor of medicine, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medical College/NewYork-Presbyterian Hospital, discusses sequencing agents for patients with multiple myeloma.
